# The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations

> **NCT05154279** · NA · UNKNOWN · sponsor: **Wael Elbanna Clinic** · enrollment: 99 (estimated)

## Conditions studied

- Laparoscopic Myomectomy

## Interventions

- **DRUG:** Terlipressin

## Key facts

- **NCT ID:** NCT05154279
- **Lead sponsor:** Wael Elbanna Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-27
- **Primary completion:** 2024-12-30
- **Final completion:** 2026-03-30
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05154279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05154279, "The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05154279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*